Not Signed In - Anesiva Starts Phase 1 Clinical Study Of 1207, New Topical Local Anesthetic
Thu, 26 Oct 2006 07:00 AM EST
... Anesiva, Inc. (Nasdaq: ANSV) announced today that it has commenced Phase 1 clinical testing of product candidate 1207, a new topical local anesthetic for the potential treatment of numerous pain conditions, including neuropathic pain. The study, designed to assess the safety of 1207, will enroll 24 adult healthy male volunteers in up to six dose-escalating cohorts in Australia. [click link for full article] ...
Related Topics
- Clinical Trials
- Benzocaine Topical
- Anesthesia
- Pharmacology
- Psychopharmacology
- Tetracaine Topical
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Clinical Growth Charts
- Diphenhydramine Topical
- Ciclopirox Topical
- Clindamycin Topical
- Local spread of the tumor with increasing pain
- Hydrocortisone, Neomycin, and Polymyxin Topical
- State and Local Integrated Telephone Survey
- Metronidazole Topical
- Health psychology
- Gentamicin Topical
- Calcipotriene Topical Solution
- Fluocinonide Topical
email this page
print this page
bookmark this page
feedback on this page
